Confounding adjustment in comparative effectiveness research conducted within distributed research networks
- PMID: 23752258
- DOI: 10.1097/MLR.0b013e31829b1bb1
Confounding adjustment in comparative effectiveness research conducted within distributed research networks
Abstract
Background: A distributed research network (DRN) of electronic health care databases, in which data reside behind the firewall of each data partner, can support a wide range of comparative effectiveness research (CER) activities. An essential component of a fully functional DRN is the capability to perform robust statistical analyses to produce valid, actionable evidence without compromising patient privacy, data security, or proprietary interests.
Objectives and methods: We describe the strengths and limitations of different confounding adjustment approaches that can be considered in observational CER studies conducted within DRNs, and the theoretical and practical issues to consider when selecting among them in various study settings.
Results: Several methods can be used to adjust for multiple confounders simultaneously, either as individual covariates or as confounder summary scores (eg, propensity scores and disease risk scores), including: (1) centralized analysis of patient-level data, (2) case-centered logistic regression of risk set data, (3) stratified or matched analysis of aggregated data, (4) distributed regression analysis, and (5) meta-analysis of site-specific effect estimates. These methods require different granularities of information be shared across sites and afford investigators different levels of analytic flexibility.
Conclusions: DRNs are growing in use and sharing of highly detailed patient-level information is not always feasible in DRNs. Methods that incorporate confounder summary scores allow investigators to adjust for a large number of confounding factors without the need to transfer potentially identifiable information in DRNs. They have the potential to let investigators perform many analyses traditionally conducted through a centralized dataset with detailed patient-level information.
Similar articles
-
Development of a privacy and security policy framework for a multistate comparative effectiveness research network.Med Care. 2013 Aug;51(8 Suppl 3):S66-72. doi: 10.1097/MLR.0b013e31829b1d9f. Med Care. 2013. PMID: 23774516
-
Multivariable confounding adjustment in distributed data networks without sharing of patient-level data.Pharmacoepidemiol Drug Saf. 2013 Nov;22(11):1171-7. doi: 10.1002/pds.3483. Epub 2013 Jul 23. Pharmacoepidemiol Drug Saf. 2013. PMID: 23878013
-
Privacy-preserving analytic methods for multisite comparative effectiveness and patient-centered outcomes research.Med Care. 2014 Jul;52(7):664-8. doi: 10.1097/MLR.0000000000000147. Med Care. 2014. PMID: 24926715
-
Building the informatics infrastructure for comparative effectiveness research (CER): a review of the literature.Med Care. 2012 Jul;50 Suppl:S38-48. doi: 10.1097/MLR.0b013e318259becd. Med Care. 2012. PMID: 22692258 Review.
-
Privacy technology to support data sharing for comparative effectiveness research: a systematic review.Med Care. 2013 Aug;51(8 Suppl 3):S58-65. doi: 10.1097/MLR.0b013e31829b1d10. Med Care. 2013. PMID: 23774511 Free PMC article. Review.
Cited by
-
Standardizing to specific target populations in distributed networks and multisite pharmacoepidemiologic studies.Am J Epidemiol. 2024 Jul 8;193(7):1031-1039. doi: 10.1093/aje/kwae015. Am J Epidemiol. 2024. PMID: 38412261 Free PMC article.
-
Feasibility Study of Federated Learning on the Distributed Research Network of OMOP Common Data Model.Healthc Inform Res. 2023 Apr;29(2):168-173. doi: 10.4258/hir.2023.29.2.168. Epub 2023 Apr 30. Healthc Inform Res. 2023. PMID: 37190741 Free PMC article.
-
An Investigation of Factors Influencing the Postponement of the Use of Distributed Research Networks in South Korea: Web-Based Users' Survey Study.JMIR Form Res. 2023 Apr 12;7:e40660. doi: 10.2196/40660. JMIR Form Res. 2023. PMID: 37043286 Free PMC article.
-
Long-term Mortality in Individuals Diagnosed With Cancer During Pregnancy or Postpartum.JAMA Oncol. 2023 Jun 1;9(6):791-799. doi: 10.1001/jamaoncol.2023.0339. JAMA Oncol. 2023. PMID: 37022714 Free PMC article.
-
Cancer Research Line (CAREL): Development of Expanded Distributed Research Networks for Prostate Cancer and Lung Cancer.Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338221149262. doi: 10.1177/15330338221149262. Technol Cancer Res Treat. 2023. PMID: 36977531 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
